Johnson & Johnson (JNJ) : 19 analysts are covering Johnson & Johnson (JNJ) and their average rating on the stock is 2.26, which is read as a Buy. 7 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Johnson & Johnson (JNJ) also receives 2 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 2, which recommends a Buy affirms that they expect a large upside in the stock from the current levels. However, 1 analysts consider that the stock has more downward risks ahead, hence, they suggest a Strong Sell on the stock. A total of 9 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.
Johnson & Johnson (JNJ) : 13 Wall Street analysts covering Johnson & Johnson (JNJ) believe that the average level the stock could reach for the short term is $124.54. The maximum price target given is $142 and the minimum target for short term is around $93, hence the standard deviation is calculated at $14.78.
For the current week, the company shares have a recommendation consensus of Buy. Also, Major Brokerage house, Argus Research upgrades its ratings on Johnson & Johnson (NYSE:JNJ). In the latest research report, Argus Research raises the target price from $130 per share to $145 per share. According to the latest information available, the shares are now rated Buy by the analysts at the agency. Previously, the analysts had a Hold rating on the shares. The rating by the firm was issued on July 20, 2016.
Johnson & Johnson (NYSE:JNJ): The stock opened at $125.00 on Wednesday but the bulls could not build on the opening and the stock topped out at $125.00 for the day. The stock traded down to $123.69 during the day, due to lack of any buying support eventually closed down at $123.90 with a loss of -0.76% for the day. The stock had closed at $124.85 on the previous day. The total traded volume was 5,310,641 shares.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.